August 15, 2015 Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool
July 28, 2015 Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
July 14, 2015 The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification
July 8, 2015 Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C
June 26, 2015 Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research
June 15, 2015 Assessing the Landscape of Tools and Approaches for Novel Tuberculosis Regimen Development
January 11, 2015 “Bring Your Own Device” (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials?